Public health relevance of medicines developed under paediatric legislation in Europe and the USA: a systematic mapping study
Background Legislation in the European Union (EU) and the USA promoting the development of paediatric medicines has contributed to new treatments for children. This study explores how such legislation responds to paediatric health needs in different country settings and globally, and whether it shou...
Main Authors: | Albrecht Jahn, Rosa Jahn, Anna Volodina |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-05-01
|
Series: | BMJ Paediatrics Open |
Online Access: | https://bmjpaedsopen.bmj.com/content/8/1/e002455.full |
Similar Items
-
Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines
by: Albrecht Jahn, et al.
Published: (2024-05-01) -
Paediatric Medicines in Europe: The Paediatric Regulation—Is It Time for Reform?
by: Maddalena Toma, et al.
Published: (2021-02-01) -
Public-private knowledge transfer and access to medicines: a systematic review and qualitative study of perceptions and roles of scientists involved in HPV vaccine research
by: Rosa Jahn, et al.
Published: (2020-03-01) -
COVID-19 in Ghana: challenges and countermeasures for maternal health service delivery in public health facilities
by: Faith Agbozo, et al.
Published: (2021-07-01) -
The european paediatric legislation: benefits and perspectives
by: Rocchi Francesca, et al.
Published: (2010-08-01)